Boehringer Ingelheim, A*STAR ink pact for targeted cancer therapies Ruchika Sharma4 Jun 2022 10:00 AM ISTA*STAR may receive payments totalling 100 million EUR in upfront and success-based development and commercialization milestones.
Boehringer Ingelheim's empagliflozin gets CDSCO nod for heart failure with preserved ejection fraction Medical Dialogues Bureau19 May 2022 4:19 PM ISTNew Delhi: Boehringer Ingelheim, one of the world's leading, research-driven pharmaceutical companies, has received approval from the Central Drugs...
Violation of drugs patents: Boehringer Ingelheim demands mechanisms in place Roshni Dhar26 April 2022 2:20 PM ISTDrug major Boehringer Ingelheim India has urged authorities to put in place a system that will inform patent holders whenever an application is filed...
Health Bulletin 23/April/2022 Roshni Dhar23 April 2022 5:34 PM ISTHere are the Top Health stories of the day:Foreign MBBS medicos must secure 50 percent marks in 10+2 to appear in FMGE: Delhi HCDismissing the plea by...
Violation of Drugs Patents: Boehringer Ingelheim demands authorities set mechanisms in place Ruchika Sharma21 April 2022 3:42 PM ISTA notification system would be helpful if any manufacturer files for approval with a state government and the DCGI and the patent holder is notified...
Boehringer operating income edges up on Jardiance, animal health Ruchika Sharma6 April 2022 9:00 AM ISTFrankfurt: Germany's unlisted Boehringer Ingelheim said operating income rose 1.8% in 2021, driven by more prescriptions of diabetes drug Jardiance...
Boehringer Ingelheim gets USFDA Breakthrough Therapy Designation for BI 1015550 MD Bureau28 Feb 2022 11:00 AM ISTGermany: Boehringer Ingelheim has announced that the U.S. Food and Drug Administration (USFDA) has granted Breakthrough Therapy Designation to its...
Boehringer Ingelheim bags Guinness World Records title for stroke awareness campaign Ruchika Sharma26 Nov 2021 3:35 PM ISTNew Delhi: Boehringer Ingelheim India, has recently announced that the company has achieved the Guinness World Records title for "Most...
Boehringer Ingelheim gets CDSCO panel nod to market Jardiance for additional indication Roshni Dhar1 Nov 2021 11:24 AM ISTIn a significant development, drug-major Boehringer has got a go ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Boehringer Ingelheim Cyltezo gets USFDA nod as 1st iterchangeable biosimilar with Humira Ruchika Sharma17 Oct 2021 11:00 AM ISTRidgefield: Boehringer Ingelheim has recently announced that the U.S. Food and Drug Administration (USFDA) has approved the supplemental Biologics...
Boehringer Ingelheim launches University of Medicine Excellence Ruchika Sharma13 Oct 2021 10:00 AM ISTIngelheim: Boehringer Ingelheim has recently announced the launch of its University of Medicine Excellence (UME). In an unequivocal demonstration of...
Boehringer Ingelheim finds Country MD for India in Vani Manja Ruchika Sharma12 Jan 2021 11:30 AM ISTNew Delhi: Drug firm Boehringer Ingelheim on Monday said it has appointed Vani Manja as country Managing Director for India, effective January 1,...
